-
1
-
-
0021880217
-
Disposition of mitoxantrone in cancer patients
-
Alberts DS, Peng YM, Leigh S, Davis TP and Woodward DL (1985) Disposition of mitoxantrone in cancer patients. Cancer Res 45: 1879-1884
-
(1985)
Cancer Res
, vol.45
, pp. 1879-1884
-
-
Alberts, D.S.1
Peng, Y.M.2
Leigh, S.3
Davis, T.P.4
Woodward, D.L.5
-
2
-
-
0028115696
-
Escalating dose of mitoxantrone with high-dose cyclophosphamide, carmustine, and etoposide in patients with refractory lymphoma undergoing autologous bone marrow transplantation
-
Attal M, Canal P, Schlaifer D, Chatelut E, Dezeuze A, Huguet F, Payen C, Pris J and Laurent G (1994) Escalating dose of mitoxantrone with high-dose cyclophosphamide, carmustine, and etoposide in patients with refractory lymphoma undergoing autologous bone marrow transplantation. J Clin Oncol 12: 141-148
-
(1994)
J Clin Oncol
, vol.12
, pp. 141-148
-
-
Attal, M.1
Canal, P.2
Schlaifer, D.3
Chatelut, E.4
Dezeuze, A.5
Huguet, F.6
Payen, C.7
Pris, J.8
Laurent, G.9
-
3
-
-
0027453573
-
Dose escalation of mitoxantrone given with thiotepa and autologous bone marrow transplantation for metastatic breast cancer
-
Bowers C, Adkins D, Dunphy F, Harrison B, LeMaistre CF and Spitzer G (1993) Dose escalation of mitoxantrone given with thiotepa and autologous bone marrow transplantation for metastatic breast cancer. Bone Marrow Transplant 12: 525-530
-
(1993)
Bone Marrow Transplant
, vol.12
, pp. 525-530
-
-
Bowers, C.1
Adkins, D.2
Dunphy, F.3
Harrison, B.4
LeMaistre, C.F.5
Spitzer, G.6
-
4
-
-
0027363072
-
Plasma and cellular pharmacokinetics of mitoxantrone in high-dose chemotherapeutic regimen for refractory lymphomas
-
Canal P, Attal M, Chatelut E, Guichard S, Huguet F, Muller C, Schlaifer D, Laurent G, Houin G and Bugat R (1993) Plasma and cellular pharmacokinetics of mitoxantrone in high-dose chemotherapeutic regimen for refractory lymphomas. Cancer Res 53: 4850-4854
-
(1993)
Cancer Res
, vol.53
, pp. 4850-4854
-
-
Canal, P.1
Attal, M.2
Chatelut, E.3
Guichard, S.4
Huguet, F.5
Muller, C.6
Schlaifer, D.7
Laurent, G.8
Houin, G.9
Bugat, R.10
-
6
-
-
0025651011
-
A phase I-II study of high-dose cyclophosphamide, thiotepa and escalating dose of mitoxantrone with autologous stem cell rescue in patients with refractory malignancies
-
Ellis ED, William SF, Moormeier JA, Kaminer LS and Bitran JD (1990) A phase I-II study of high-dose cyclophosphamide, thiotepa and escalating dose of mitoxantrone with autologous stem cell rescue in patients with refractory malignancies. Bone Marrow Transplant 6: 439-442
-
(1990)
Bone Marrow Transplant
, vol.6
, pp. 439-442
-
-
Ellis, E.D.1
William, S.F.2
Moormeier, J.A.3
Kaminer, L.S.4
Bitran, J.D.5
-
7
-
-
0027429618
-
Phase I clinical and pharmacokinetic evaluation of high-dose mitoxantrone in combination with cytarabine in patients with acute leukemia
-
Feldman EJ, Alberts DS, Arlin Z, Ahmed A, Mittelman A, Baskind, Peng Y-M, Baier M and Plezia P (1993) Phase I clinical and pharmacokinetic evaluation of high-dose mitoxantrone in combination with cytarabine in patients with acute leukemia. J Clin Oncol 11: 2002-2009
-
(1993)
J Clin Oncol
, vol.11
, pp. 2002-2009
-
-
Feldman, E.J.1
Alberts, D.S.2
Arlin, Z.3
Ahmed, A.4
Mittelman, A.5
Baskind6
Peng, Y.-M.7
Baier, M.8
Plezia, P.9
-
8
-
-
0022492174
-
Comparison of mitoxantrone and ametantrone in human acute myelocytic leukemia cells in culture and in bone marrow granulocyte-macrophage progenitor cells
-
Fountzilas G, Ohnuma T, Rammos K, Mindich B and Holland FJ (1986) Comparison of mitoxantrone and ametantrone in human acute myelocytic leukemia cells in culture and in bone marrow granulocyte-macrophage progenitor cells. Cancer Drug Delivery 3: 93-100
-
(1986)
Cancer Drug Delivery
, vol.3
, pp. 93-100
-
-
Fountzilas, G.1
Ohnuma, T.2
Rammos, K.3
Mindich, B.4
Holland, F.J.5
-
9
-
-
0023729443
-
When can the infusion period be safely ignored in the estimation of pharmacokinetic parameters of drugs in humans?
-
Freedman LS and Workman P (1988) When can the infusion period be safely ignored in the estimation of pharmacokinetic parameters of drugs in humans? Cancer Chemother Pharmacol 22: 95-103
-
(1988)
Cancer Chemother Pharmacol
, vol.22
, pp. 95-103
-
-
Freedman, L.S.1
Workman, P.2
-
10
-
-
0002991458
-
Pharmacologic strategies for high-dose chemotherapy
-
Armitage JO and Antman KH (eds), Williams & Wilkins: Baltimore
-
Frei E (1995) Pharmacologic strategies for high-dose chemotherapy. In High-dose Cancer Therapy. Armitage JO and Antman KH (eds), pp. 3-16. Williams & Wilkins: Baltimore
-
(1995)
High-dose Cancer Therapy
, pp. 3-16
-
-
Frei, E.1
-
11
-
-
0018931869
-
Dose: A critical factor in cancer therapy
-
Frei E and Canellos GP (1980) Dose: A critical factor in cancer therapy. Am J Med 69: 585-594
-
(1980)
Am J Med
, vol.69
, pp. 585-594
-
-
Frei, E.1
Canellos, G.P.2
-
12
-
-
0023945042
-
Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium
-
Gabrilove JL, Jakubosky A, Sher H, Stenberg C, Wong G, Grous J, Yagoda A, Fain K, Malcom MAS, Clarkson B, Oettgen HF, Alton K, Weite K and Souza L (1988) Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium. N Engl J Med 318: 1414-1422
-
(1988)
N Engl J Med
, vol.318
, pp. 1414-1422
-
-
Gabrilove, J.L.1
Jakubosky, A.2
Sher, H.3
Stenberg, C.4
Wong, G.5
Grous, J.6
Yagoda, A.7
Fain, K.8
Malcom, M.A.S.9
Clarkson, B.10
Oettgen, H.F.11
Alton, K.12
Weite, K.13
Souza, L.14
-
13
-
-
0024380739
-
High-dose chemo-radiotherapy for sensitive tumors: Is sequential better than concurrent drug delivery?
-
Gianni AM and Bonadonna G (1989) High-dose chemo-radiotherapy for sensitive tumors: Is sequential better than concurrent drug delivery? Eur J Cancer Clin Oncol 25: 1027-1030
-
(1989)
Eur J Cancer Clin Oncol
, vol.25
, pp. 1027-1030
-
-
Gianni, A.M.1
Bonadonna, G.2
-
16
-
-
0027772976
-
Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony-stimulating factor and interleukin3 on hematopoietic progenitors in human long-term bone marrow cultures
-
Lemoli RM and Gulati SC (1993) Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony-stimulating factor and interleukin3 on hematopoietic progenitors in human long-term bone marrow cultures. Stem Cells 11: 435-444
-
(1993)
Stem Cells
, vol.11
, pp. 435-444
-
-
Lemoli, R.M.1
Gulati, S.C.2
-
17
-
-
0029561265
-
High-dose chemotherapy for breast cancer: Clinical advantages of autologous peripheral blood progenitor cells (PBPC) compared with autologous bone marrow transplantation (ABMT)
-
Martin M (1995) High-dose chemotherapy for breast cancer: clinical advantages of autologous peripheral blood progenitor cells (PBPC) compared with autologous bone marrow transplantation (ABMT) Ann Oncol 6 (suppl. 4): S33-S37
-
(1995)
Ann Oncol
, vol.6
, Issue.4 SUPPL.
-
-
Martin, M.1
-
18
-
-
0024411287
-
High-dose cyclophosphamide or melphalan with escalating doses of mitoxantrone and autologous bone marrow transplantation for refractory solid tumors
-
Mulder POM, Sleijfer DT, Willemse PHB, De Vries EGE, Uges DRA and Mulder NH (1989) High-dose cyclophosphamide or melphalan with escalating doses of mitoxantrone and autologous bone marrow transplantation for refractory solid tumors. Cancer Res 49: 4654-4658
-
(1989)
Cancer Res
, vol.49
, pp. 4654-4658
-
-
Mulder, P.O.M.1
Sleijfer, D.T.2
Willemse, P.H.B.3
De Vries, E.G.E.4
Uges, D.R.A.5
Mulder, N.H.6
-
19
-
-
0028957912
-
Four-step high-dose sequential chemotherapy with double hematopoietic progenitor-cell rescue for metastatic breast cancer
-
Patrone F, Ballestrero A, Ferrando F, Brema F, Moraglio L, Valbonesi M, Basta P, Ohio R, Gobbi M, and Sessarego M (1995) Four-step high-dose sequential chemotherapy with double hematopoietic progenitor-cell rescue for metastatic breast cancer. J Clin Oncol 13: 840-846
-
(1995)
J Clin Oncol
, vol.13
, pp. 840-846
-
-
Patrone, F.1
Ballestrero, A.2
Ferrando, F.3
Brema, F.4
Moraglio, L.5
Valbonesi, M.6
Basta, P.7
Ohio, R.8
Gobbi, M.9
Sessarego, M.10
-
20
-
-
0020333639
-
Improved high-performance liquid chromatography of the new antineoplastic agents bisantrene and mitoxantrone
-
Peng YM, Ormberg D and Alberts DS (1982) Improved high-performance liquid chromatography of the new antineoplastic agents bisantrene and mitoxantrone. J Chromatog Biomed Appl 233: 235-247
-
(1982)
J Chromatog Biomed Appl
, vol.233
, pp. 235-247
-
-
Peng, Y.M.1
Ormberg, D.2
Alberts, D.S.3
-
21
-
-
0026528464
-
Pharmacokinetics of mitoxantrone in cancer patients treated by high-dose chemotherapy and autologous bone-marrow transplantation
-
Richard B, Launay-Iliadis MC, Iliadis A, Just-Landi S, Blaise D, Stoppa AM, Viens P, Gaspard MH, Maraninchi D, Cano JP and Carcassonne Y (1992) Pharmacokinetics of mitoxantrone in cancer patients treated by high-dose chemotherapy and autologous bone-marrow transplantation. Br J Cancer 65: 399-404
-
(1992)
Br J Cancer
, vol.65
, pp. 399-404
-
-
Richard, B.1
Launay-Iliadis, M.C.2
Iliadis, A.3
Just-Landi, S.4
Blaise, D.5
Stoppa, A.M.6
Viens, P.7
Gaspard, M.H.8
Maraninchi, D.9
Cano, J.P.10
Carcassonne, Y.11
-
22
-
-
0025980856
-
Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients
-
Siena S, Bregni M, Brando B, Belli N, Ravagnani F, Gandola L, Stern AC, Lansdorp PM, Bonadonna G and Gianni AM (1991) Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 77: 400-409
-
(1991)
Blood
, vol.77
, pp. 400-409
-
-
Siena, S.1
Bregni, M.2
Brando, B.3
Belli, N.4
Ravagnani, F.5
Gandola, L.6
Stern, A.C.7
Lansdorp, P.M.8
Bonadonna, G.9
Gianni, A.M.10
-
23
-
-
0027383240
-
Clinical implications of the heterogeneity of hematopoietic progenitors elicited in peripheral blood by anticancer therapy with cyclophosphamide and cytokine(s)
-
Siena S, Bregni M, Bonsi L, Strippoli P, Peccatori F, Magni M, Di Nicola M, Bagnara GP and Gianni AM (1993) Clinical implications of the heterogeneity of hematopoietic progenitors elicited in peripheral blood by anticancer therapy with cyclophosphamide and cytokine(s). Stem Cells 11 (suppl. 2): 72-75
-
(1993)
Stem Cells
, vol.11
, Issue.2 SUPPL.
, pp. 72-75
-
-
Siena, S.1
Bregni, M.2
Bonsi, L.3
Strippoli, P.4
Peccatori, F.5
Magni, M.6
Di Nicola, M.7
Bagnara, G.P.8
Gianni, A.M.9
-
24
-
-
0027952666
-
Phase I clinical and pharmacokinetic study of high-dose mitoxantrone combined with carboplatin, cyclophosphamide, and autologous bone marrow rescue: High response rate for refractory ovarian carcinoma
-
Stiff PJ, McKenzie RS, Alberts DS, Sosman JA, Dolan JR, Rad N and McCloskey T (1994) Phase I clinical and pharmacokinetic study of high-dose mitoxantrone combined with carboplatin, cyclophosphamide, and autologous bone marrow rescue: high response rate for refractory ovarian carcinoma. J Clin Oncol 12: 176-183
-
(1994)
J Clin Oncol
, vol.12
, pp. 176-183
-
-
Stiff, P.J.1
McKenzie, R.S.2
Alberts, D.S.3
Sosman, J.A.4
Dolan, J.R.5
Rad, N.6
McCloskey, T.7
-
25
-
-
0027444652
-
A predictive model for aggressive non-Hodgkin's lymphoma
-
The International Non-Hodgkin's Lymphoma Prognostic Factors Project (1993) A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 329: 987-994
-
(1993)
N Engl J Med
, vol.329
, pp. 987-994
-
-
-
26
-
-
0023022033
-
Pharmacokinetics of mitoxantrone in human following single-agent infusion or intra-arterial injection therapy or combined-agent infusion therapy
-
Van Belle SJP, dE Planque MM, Smith IE, Van Oosterom AT, Schoemaker TJ, Deneve W and McVie JG (1986) Pharmacokinetics of mitoxantrone in human following single-agent infusion or intra-arterial injection therapy or combined-agent infusion therapy. Cancer Chemother Pharmacol 18: 27-32
-
(1986)
Cancer Chemother Pharmacol
, vol.18
, pp. 27-32
-
-
Van Belle, S.J.P.1
De Planque, M.M.2
Smith, I.E.3
Van Oosterom, A.T.4
Schoemaker, T.J.5
Deneve, W.6
McVie, J.G.7
-
27
-
-
0022917013
-
Use of in vitro dose response effect to select antineoplastics for high-dose or regional administration regimens
-
Von Hoff DD, Clark GM, Weiss GR, marshall MH, Buchok JB, Knight WA III and LeMaistre CF (1986) Use of in vitro dose response effect to select antineoplastics for high-dose or regional administration regimens. J Clin Oncol 4: 1827-1834
-
(1986)
J Clin Oncol
, vol.4
, pp. 1827-1834
-
-
Von Hoff, D.D.1
Clark, G.M.2
Weiss, G.R.3
Marshall, M.H.4
Buchok, J.B.5
Knight III, W.A.6
LeMaistre, C.F.7
-
28
-
-
0025089428
-
A phase II study of mitoxantrone, etoposide, and thiotepa with autologous marrow support for patients with relapsed breast cancer
-
Wallerstein R, Spitzer G, Dunphy F, Huan S, Hortobagyi G, Yau J, Buzdar A, Holmes F, Theriault R, Ewer M, LeMaistre CF, Dicke K and Deisseroth A (1990) A phase II study of mitoxantrone, etoposide, and thiotepa with autologous marrow support for patients with relapsed breast cancer. J Clin Oncol 8: 1782-1788
-
(1990)
J Clin Oncol
, vol.8
, pp. 1782-1788
-
-
Wallerstein, R.1
Spitzer, G.2
Dunphy, F.3
Huan, S.4
Hortobagyi, G.5
Yau, J.6
Buzdar, A.7
Holmes, F.8
Theriault, R.9
Ewer, M.10
LeMaistre, C.F.11
Dicke, K.12
Deisseroth, A.13
|